Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre

Bibliographic Details
Title: Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre
Authors: Velina Nedkova-Hristova, Valentina Vélez-Santamaría, Carlos Casasnovas
Source: BMC Neurology, Vol 20, Iss 1, Pp 1-5 (2020)
Publisher Information: BMC, 2020.
Publication Year: 2020
Collection: LCC:Neurology. Diseases of the nervous system
Subject Terms: Melatonin, Myasthenia gravis, Corticosteroid, Immunosuppressant, Case report, Neurology. Diseases of the nervous system, RC346-429
More Details: Abstract Background Myasthenia gravis is an autoimmune disease mediated by antibodies against proteins associated with the postsynaptic membrane of the neuromuscular junction. Several drugs may trigger an exacerbation of the disease. Melatonin supplements are widely used for the treatment of insomnia as they are well tolerated with few side effects. The role of melatonin in the immune system and its effects in autoimmune disorders remain uncertain. Case presentation We identified three patients in our referral centre from 2014 to 2019 who presented a worsening within days or weeks of starting melatonin. Two of them stopped the treatment without clinical improvement in the next week. Increasing dose of corticosteroids did not lead to clinical improvement in the next month and one of the patients was finally administered intravenous immunoglobulins. Conclusion Melatonin may trigger exacerbations of myasthenia gravis, probably due to an upregulation of the adaptive immune system and an interaction with the corticosteroids and other immunosuppressant treatments. We consider that melatonin should be administered with caution in these patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1471-2377
Relation: http://link.springer.com/article/10.1186/s12883-020-01975-y; https://doaj.org/toc/1471-2377
DOI: 10.1186/s12883-020-01975-y
Access URL: https://doaj.org/article/c617ba0283a04896a1a461313567eafb
Accession Number: edsdoj.617ba0283a04896a1a461313567eafb
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14712377
DOI:10.1186/s12883-020-01975-y
Published in:BMC Neurology
Language:English